PRINCETON RESEARCH, INC.

We Are Not Affiliated
With
Princeton University
Mike King is the director, head of research and chief economist of Princeton Research, Inc. of Nevada. He has over 35 years of cumulative experience beginning as a broker/trader to consulting corporations on financial matters, which later evolved into investment banking and corporate finance for private and public companies. His penchant over the years has been specializing in economic analysis of public companies, equities, derivatives, and physicals or cash market trends throughout the world.

Princeton Research is NOT Affiliated in any way with Princeton University.

Please note that this web site is for informational purposes only. No part of this site is to be considered stock solicitation or an offer to
buy or sell securities. No investment advice of any kind is to be inferred from this site. This site contains "forward looking statements" as
defined by SEC regulations. Opinions expressed are those of Mike King and the Princeton Research staff. Companies mentioned on this site have neither approved nor disapproved this site content. All information shown was obtained from data available on the Internet.

Here at Princeton Research, Inc. it is our policy to provide news, information on and links to featured companies and investment opportunities that we believe have the potential to produce high returns.
Copyright © 2004-2009 Mike King And Princeton Research, Inc. ALL RIGHTS RESERVED.
Reproduction or distribution of any or all material on this web site or in Mike Kings’s and Princeton Research Newsletters are strictly prohibited without expressed written consent.
All content, images and material on this site is protected by International copyright laws.
Princeton Research, Inc. Investment Strategies For Success Policy Statement
Rule 17B Requirements -- Disclosure of Payment for Investor Relations

Princeton Research has received about $2,500 per month from MTBR with asterisk.
MTBR is reviewing a contract which would pay $2,500 per month plus some restricted shares.
The main principal of Princeton Research has obtained his own shares amounting to 2,500,000 shares.
Stemulite Fitness
Formula Is
Endorsed By
Many Top Athletes
Including:

SIMEON RICE
NFL All Pro
Football Player
Get
INSTANT
ALERTS
Follow
Mike On
TWITTER @High
Return

Click Here
METABOLIC RESEARCH, Inc. (Stock Symbol: MTBR - Click For Quote)
METABOLIC RESEARCH, Inc. (Stock Symbol: MTBR - Click For Recent News)
METABOLIC RESEARCH, Inc.
Click Here For Corporate Site
METABOLIC RESEARCH Is The Developer Of
StemuliteTM Fitness Formula

The Powerful, Legal, Natural, No Side Effect, Healthy Alternative To Steroids
Body Building, Weight Loss And Peak Fitness
Learn More About Stemulite Fitness Formula

Click Here For The Natural Peak Performance Page
METABOLIC RESEARCH, Inc. (Stock Symbol: MTBR - Click For Quote)
METABOLIC RESEARCH, Inc. (Stock Symbol: MTBR - Click For Recent News)
New Marketing Vice President Appointed:
Pete Danielson brings the company 20 years of successful "Brand Marketing" Experience
-- June 25, 2009 --- Read The Full news Release Click Here
Profitable 2009 1ST Quarter Announced:
First Quarter 2009 Sales Of $791,410 Resulted In A Net Profit Of $229,279
-- May 21, 2009 --- Read The Full news Release Click Here
METABOLIC RESEARCH'S STRATEGIC ALLIANCE TO DEVELOP, MARKET AND
DISTRIBUTE A NATURAL CANCER DRUG


The company has a strategic alliance with Cornerstone Pharmaceuticals with respect to the development, acquisition, manufacturing, marketing and distribution of nutritional supplements for the immune system support against cancer. To that end, the company intends to acquire an additional license agreement for such non-synthetic cancer-fighting product, a natural beta glucan/lectin combination drug.

Read More --- Click Here
A NEW METHOD FOR 'GROWING' DRUGS

Background on Medicinal Mushrooms:
Only recently has Western society found what Eastern cultures have long known for centuries, that fungi, especially mushrooms have within them some of the most potent nutritional substances and medicine found in nature. Their cellular constituents can profoundly improve the quality of human health. Differing from most pharmaceuticals, these healing agents have extraordinarily low toxicity, even at high doses. Acupuncture and the use of Traditional Chinese Medicine (TCM) are examples of East-West merger of medical treatments.

Read More --- Click Here
TECHNOLOGY DESCRIPTION

A breakthrough discovery using fungi, plant, or animal sources to produce anti-inflammatory and analgesic products to both treat and cure inflammatory disease includes a Provisional Patent application titled: Composition and Method of Producing Endogenous Therapeutic Anti Inflammatory Eicosanoids and their Metabolites by Exogenous or Oral Means.

Read More --- Click Here